Tadalafil Tablet
Product Images NDC 82009-080

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 82009-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20mg (Tadalafil 20mg60)

FDA Label Image

Figure1 (Tadalafil Fig1)

FDA Label Image

Figure2 (Tadalafil Fig2)

FDA Label Image

Figure3 (Tadalafil Fig3)

FDA Label Image

Figure4 (Tadalafil Fig4)

Mean Change from Baseline (Meters) - There are different measurements provided for the mean change from baseline in meters. - The values range from 50 meters to 10 meters. Treatment Groups: - There are two treatment groups mentioned: Placebo and Tadalafil 40 mg. - The number of participants (N) for the Placebo group is not specified. - The number of participants (N) for the Tadalafil 40 mg group is 79. Statistical Significance: - The statistical significance is mentioned using p-values. - There are four p-values provided: 0.0152, 0.0084, 0.00004, and 0.*

FDA Label Image

Figure5 (Tadalafil Fig5)

FDA Label Image

Figure6 (Tadalafil Fig6)

FDA Label Image

Logo (Tadalafil Logo)

FDA Label Image

Tadalafil_structure (Tadalafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.